16 November, 2021 - Groningen, the Netherlands

This two-day Hybrid AF™ Convergent Therapy Program (16-17 November 2021) is led by a faculty of electrophysiologist and cardiac surgeon. The comprehensive program includes both didactic sessions, the opportunity to perform Convergent Approach cases in a beating heart specimen model, and live case observations.

This training program is now fully booked and registration is no longer possible. Please check other available dates for the Hybrid AF™ Convergent Therapy Program.

16 November: Didactics and cadaver lab
17 November: Live observation (1 surgical and 1 EP case)

The specialized curriculum is designed to facilitate data and experience exchange, providing peer-to-peer led training that incorporates patient selection, pre-and post-operative management, latest clinical evidence and procedural techniques.

At the end of this program, you will be able to discuss how to start a Hybrid AF™ Convergent Program at your hospital and how to proceed with your first scheduled cases.

Audience:
Cardiac surgeons and electrophysiologists who want to implement a Hybrid AF™ Convergent Therapy with EpiSense.

Learning objectives:
– Implementing a Hybrid AF™ Convergent Therapy
– Patient selection criteria
– Pre-and postoperative considerations
– Overview of mapping
– Review the latest clinical evidence
– Perform Convergent approach cases in a beating heart specimen model
– Intraoperative set-up
– Procedural techniques
– Management of LAA exclusion

Venue:
Universitair Medisch Centrum (UMC) Groningen
Hanzeplein 1
9713 GZ Groningen
The Netherlands

Accommodation:
NH Hotel (across the street of hospital)
Hanzeplein 132
9713 GW Groningen
The Netherlands